Plasticity of the human IgM repertoire in response to long‐term spaceflightmarketing2021-02-11T20:09:45+00:00October 13th, 2020|2020 Publications, Featured Publications, Publications| 続きを読む
Immune recovery in patients with mantle cell lymphoma receiving long-term ibrutinib and venetoclax combination therapymarketing2021-02-11T20:11:02+00:00October 8th, 2020|2020 Publications, Publications| 続きを読む
Genetic evolution of in situ follicular neoplasia to aggressive B-cell lymphoma of germinal center subtypemarketing2021-02-11T20:13:51+00:00August 27th, 2020|2020 Publications, Publications| 続きを読む
Baseline VDJ clonotype detection using a targeted sequencing NGS assay: allowing for subsequent MRD assessmentmarketing2021-02-11T20:26:38+00:00July 22nd, 2020|2020 Publications, Publications| 続きを読む
Invivoscribe Launches New Division for Drug Development. Licenses Small Molecule Inhibitors from Domainex to Treat Acute Myeloid Leukemiamarketing2021-02-26T19:09:41+00:00July 14th, 2020|2020 プレスリリース, プレスリリース| 続きを読む
Evaluation of the polymerase chain reaction–based T-cell receptor β clonality test in the diagnosis of early mycosis fungoidesmarketing2021-02-11T21:43:52+00:00June 8th, 2020|2020 Publications, Publications| 続きを読む
Evaluation of Somatic Hypermutation Status in Chronic Lymphocytic Leukemia (CLL) in the Era of Next Generation Sequencingmarketing2021-02-11T21:47:46+00:00May 19th, 2020|2020 Publications, Publications| 続きを読む
Invivoscribeは、米国で体外診断用キットとしてFDAによりリューコストラットCDx FLT3変異検査®の販売が承認されたことを発表marketing2021-12-29T16:44:04+00:00May 19th, 2020|2020 プレスリリース, プレスリリース| 続きを読む
Invivoscribe to Participate in Virtual ASCO 2020marketing2020-05-27T18:13:43+00:00May 15th, 2020|Events, Upcoming Events| 続きを読む
Invivoscribe to Exhibit at 25th EHA Annual Congressmarketing2020-05-27T18:11:58+00:00May 15th, 2020|Events, Upcoming Events| 続きを読む